ctva-20210201
false000175567200017556722021-02-012021-02-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of Earliest Event Reported): February 1, 2021 
Corteva, Inc.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware 001-38710 82-4979096
(State or other jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
 
974 Centre Road, Building 735
Wilmington, Delaware 19805
(Address of principal executive offices)(Zip Code)
 
(302) 485-3000
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share CTVA New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o





Item 2.02     Results of Operations and Financial Condition
On February 3, 2021, Corteva, Inc. (the "Company") announced its consolidated financial results for the quarter and year ended December 31, 2020. A copy of the Company’s press release and financial statement schedules are furnished herewith on Form 8-K as Exhibits 99.1 and 99.2, respectively. The information contained in this report, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. In addition, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.

Item 2.05 Costs Associated with Exit or Disposal Activities
On February 1, 2021, Corteva, Inc. (“Corteva”) approved restructuring actions designed to right-size and optimize footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. Corteva expects to record total pre-tax restructuring and asset-related charges of approximately $130 million - $170 million, comprised of approximately $40 million - $50 million of severance and related benefit costs, $40 million - $60 million of asset related charges, $10 million - $15 million of asset retirement obligations and $40 million - $45 million of costs related to contract terminations. Future cash payments related to this charge are anticipated to be approximately $90 million - $110 million, primarily related to the payment of severance and related benefits, asset retirement obligations, and costs related to contract terminations. The restructuring actions associated with this charge are expected to be substantially complete in 2021.

Cautionary Statement About Forward-Looking Statements
This report contains estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “guidance”, "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates" or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva's strategy for growth, timing of anticipated benefits from restructuring actions, expenditures, and financial results are forward-looking statements. Forward-looking statements and other estimates are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond Corteva's control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in our forward-looking statements and other estimates could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva's business, results of operations and financial condition. Some of the important factors that could cause Corteva's actual results to differ materially from those projected in any such forward-looking statements or estimates include: (i) failure to obtain or maintain the necessary regulatory approvals for some Corteva’s products; (ii) failure to successfully develop and commercialize Corteva’s pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) effect of competition and consolidation in Corteva’s industry; (vi) effect of competition from manufacturers of generic products; (vii) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (viii) effect of climate change and unpredictable seasonal and weather factors; (ix) risks related to oil and commodity markets; (x) competitor’s establishment of an intermediary platform for distribution of Corteva's products; (xi) impact of Corteva's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xii) effect of industrial espionage and other disruptions to Corteva’s supply chain, information technology or network systems; (xiii) effect of volatility in Corteva’s input costs; (xiv) failure to realize the anticipated benefits of the internal reorganizations taken by DowDuPont in connection with the spin-off of Corteva and other cost savings initiatives; (xv) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xvi) failure of Corteva’s customers to pay their debts to Corteva, including customer financing programs; (xvii) increases in pension and other post-employment benefit plan funding obligations; (xviii) risks related to the indemnification obligations of legacy EID liabilities in connection with the separation of Corteva; (xix) effect of compliance with laws and requirements and adverse judgments on litigation; (xx) risks related to Corteva’s global operations; (xxi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions; failure to enforce; (xxii) risks related to COVID-19; (xxiii) risks related to activist stockholders; (xxiv) Corteva’s intellectual property rights or defend against intellectual property claims



asserted by others; (xxv) effect of counterfeit products; (xxvi) Corteva’s dependence on intellectual property cross-license agreements; and (xxvii) other risks related to the Separation from DowDuPont.

Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva's management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement or other estimate, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements and estimates is included in the "Risk Factors" section of Corteva's Annual Report on Form 10-K, as modified by subsequent quarterly reports on Form 10-Q and Current Reports on Form 8-K.


Item 9.01     Financial Statements and Exhibits

(d)    Exhibits.
Press Release dated February 3, 2021
Financial Statement Schedules dated February 3, 2021
104The cover page from the Company’s Current Report on Form 8-K, formatted in Inline XBRL








SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 CORTEVA, INC.
 (Registrant)
  
  
 /s/ Brian Titus
 Brian Titus
 Vice President and Controller
 
February 3, 2021


a02032021_4qfyx2020xearn
1 Corteva Reports Fourth Quarter and Full Year 2020 Results, Provides 2021 Guidance WILMINGTON, Del., February 3, 2021 – Corteva, Inc. (NYSE: CTVA) (“Corteva” or the “Company”) today reported financial results for the fourth quarter and 12 months ended December 31, 2020. 4Q 2020 Results Overview Net Sales EPS Income from Cont. Ops (After Tax) GAAP $3.21B $0.13 $99M vs. 4Q 2019 +8% +317% +336% Organic1 Sales Operating EPS1 Operating EBITDA1 NON-GAAP $3.46B $0.04 $236M vs. 4Q 2019 +16% (43%) +5% Full Year 2020 Highlights • Full year 2020 net sales grew 3% versus prior year. Organic1 sales rose 8% during the same period. Continued penetration of new products drove volume and price gains. Organic1 sales increased in every region, with double-digit growth in Latin America and Asia Pacific. • Crop Protection net sales grew 3% and organic1 sales increased 11% for the year. Volume and price increases were led by sales of new and differentiated products. Sales of new Crop Protection products contributed $1.0 billion to full year net sales – a 35% increase versus prior year. Collectively, gains in volume and price more than offset currency headwinds primarily attributed to the Brazilian Real and portfolio impacts. • Seed net sales increased 2% and organic1 sales grew 6% compared to prior year. Volume and local price gains were primarily driven by continued penetration of new products – more than offsetting the unfavorable impact of currency. • GAAP income and earnings per share (EPS) from continuing operations were $756 million and $0.98 per share for the full year 2020, respectively. • Operating EBITDA1 rose 5% versus 2019 to $2.1 billion, driven by volume and price gains in both Seed and Crop Protection, as well as ongoing execution on cost and productivity actions. Currency net of pricing was a $180 million headwind, inclusive of $150 million in pricing actions. • Corteva delivered cash flow from operations of $2.1 billion for the period, reflecting operational performance both in profitability and from improvements in working capital. • Management provided full year 2021 guidance8; and expects net sales in the range of $14.4 billion to $14.6 billion. Operating EBITDA is expected to be in the range of $2.4 billion to $2.5 billion, an increase of 15-20% compared to prior year. 1. Organic Sales, Operating EPS, Pro Forma Operating EPS, Operating EBITDA and Pro Forma Operating EBITDA are non-GAAP measures. See page A-6 for further discussion. 2. Full Year 2019 GAAP information is on a pro forma basis and was determined in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. Non-GAAP measures for these periods are reconciled to the GAAP pro forma measure. 3. North America is defined as U.S. and Canada. EMEA is defined as Europe, Middle East and Africa. 4. Full year 2020 improvement over prior-year Income from Continuing Operations After Income Taxes and GAAP EPS is primarily due to the absence of integration and separation charges in 2020. 5. Enlist E3™ soybeans are jointly developed by Dow AgroSciences and MS Technologies™. 6. Represents coverage of total North America market, including branded, competitors and licensees. 7. Launches pending all applicable regulatory approvals. 8. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See page 6 for further discussion. FY 2020 Results Overview Net Sales EPS4 Income from Cont. Ops (After Tax)4 GAAP $14.2B $0.98 $756M vs. Full Year 20192 +3% +4,800% +2,808% Organic1 Sales Operating EPS1 Operating EBITDA1 NON-GAAP $15.0B $1.50 $2.1B vs. Full Year 20192 +8% +5% +5% News Release 4Q/Full Year


 
News Release 4Q/Full Year 2 Company Update Building Momentum behind Accelerated Enlist™ Ramp-Up – Delivering Progress on Conkesta E3® Soybeans Corteva continues to make solid progress on the accelerated ramp-up of its Enlist E3™5 soybeans and its Enlist One® and Enlist Duo® herbicides. Strong early demand for Enlist™ herbicides in the U.S. was evident in fourth quarter sales, which more than doubled versus prior year to $140 million. Building on this accelerated progress, the Company delivered $440 million in sales for the full Enlist™ system in 2020 – further solidifying expectations of rapid adoption for this technology. Incremental Enlist™ herbicides progress was underpinned by strong Seed sales, with Enlist E3™5 soybeans representing approximately 17% of Corteva units in North America in 20206. The Company achieved a significant regulatory milestone in Seed with its Conkesta E3® soybean technology during the quarter, with the recent positive opinion from the European Food Safety Authority (EFSA) – an important step in the continued path to commercialization7 for this technology. Generating Substantial Cash Flow through Disciplined Execution Corteva drove continued, strong execution on cash generation with total cash flows from operations of approximately $2.1 billion for the year. The Company continues to deliver progress on working capital productivity, with an 11% improvement in net working capital turns versus prior year. Delivering Value to Shareholders through Consistent, Focused Actions In 2020, the Company repurchased $275 million in common stock – and, including dividends, returned more than $660 million in total to shareholders through the end of the year. Since spin, Corteva has returned more than $875 million to shareholders – and expects to return at least $1.1 billion through dividends and share repurchases by the end of 2021, with the completion of the majority of its share repurchase program anticipated by mid-year 2021. “In 2020, Corteva delivered on our strategy, resulting in strong sales and earnings growth in the quarter and for the year. We delivered these results against the backdrop of historic market volatility and uncertainty related to the ongoing COVID-19 pandemic – a solid proof point of the strength and resilience of our global team. “Our new and differentiated products contributed to solid top-line growth. We delivered progress in 2020 on key innovations and investments, such as the accelerated ramp-up of our Enlist™ system, which exceeded our initial expectations on U.S. soybean acres in 2020. At the same time, we grew our position in key markets and regions during the year, and further strengthened our multi-channel, multi-brand strategy, including the launch of Brevant™ in the U.S. retail channel. “We view 2021 as an acceleration point on our path. We are confident that continued penetration of our high-margin technology, coupled with our cost and productivity initiatives, will result in margin expansion in the near term, with more upside further ahead. “Above all, we are committed to delivering significant value to shareholders. In 2020, we advanced our returns to shareholders through our dividends and the continued execution of our share repurchase program, which we now expect to complete by the end of 2021 – with the majority expected by mid-year. Bottom line: Our strategy is solid. Our team continues to execute. We are confident we will deliver.” James C. Collins, Jr. Chief Executive Officer


 
News Release 4Q/Full Year 3 Summary of Fourth Quarter 2020 For the fourth quarter ended December 31, 2020, net sales increased 8% versus the same period last year, as organic1 sales increased 16%. Volume grew 10% versus the prior-year period, driven primarily by continued adoption of new and differentiated Crop Protection products. The Company delivered double- digit organic1 sales gains in North America3, Latin America, and Asia Pacific, with 21% organic1 sales for the segment. Early season sales in Seed helped to offset the impact of currency in Latin America. Seed organic1 sales increased 9%, with gains in almost every region. Local price increased 6% versus prior year. Higher prices in all regions helped to offset the impact of currency, which represented a headwind of 8% globally, led by the Brazilian Real. GAAP income from continuing operations after income taxes was $99 million in fourth quarter 2020. Operating EBITDA1 for the fourth quarter was $236 million, up 5% compared to the same period last year. Continued adoption of new and differentiated technology in Seed and Crop Protection, coupled with ongoing execution on cost and productivity actions, more than offset the negative impact of currency, as well as the absence of prior-year gains on divestitures. Currency net of pricing was a $40 million headwind, inclusive of $80 million in pricing actions. Summary of Full Year 2020 For the year ended December 31, 2020, net sales increased 3% versus prior year, with organic1 sales growth of 8%. Volume increased 5% versus the year-ago period, primarily driven by sales of new and differentiated products globally and across both segments. Local price grew 3% on a full year basis, with higher prices in all regions, led by Latin America partly to offset currency. Currency represented a headwind of 5%, led by the impact of the Brazilian Real. GAAP income from continuing operations after income taxes was $756 million in 2020. Operating EBITDA1 for the full year period was $2.1 billion, an increase of 5% as compared to prior year on a pro forma basis. Favorable mix, ongoing cost and productivity actions and higher volumes more than offset the negative impact from currency. Corteva generated $2.1 billion in cash from operations for the full year. These results demonstrate effective working capital management. FY FY % % ($ in millions, except where noted) 2020 2019 Change Organic1 Change Net Sales $14,217 $13,846 3% 8% North America $7,168 $6,929 3% 4% EMEA $2,842 $2,740 4% 8% Latin America $2,805 $2,889 (3)% 17% Asia Pacific $1,402 $1,288 9% 13% 4Q 4Q % % ($ in millions, except where noted) 2020 2019 Change Organic1 Change Net Sales $3,207 $2,983 8% 16% North America $1,350 $1,129 20% 19% EMEA $417 $404 3% 4% Latin America $1,051 $1,109 (5)% 17% Asia Pacific $389 $341 14% 12%


 
News Release 4Q/Full Year 4 Crop Protection Summary Crop Protection net sales were approximately $2.0 billion in the fourth quarter of 2020, up 13% from $1.7 billion in the fourth quarter of 2019 – with 21% organic1 sales growth for the quarter. Sales gains were driven by an 11% increase in volume and a 10% increase in local price, partially offset by an 8% negative impact from currency. Volume growth was driven by strong demand for new products globally, including EnlistTM and ArylexTM herbicides and IsoclastTM insecticide. Local price rose due to increases in Latin America to offset currency, coupled with favorable product mix. Unfavorable currency impacts were led by the Brazilian Real. Segment operating EBITDA was $327 million in the fourth quarter of 2020, up from $277 million in the fourth quarter of 2019. Favorable mix, volume gains and ongoing cost and productivity actions more than offset the negative impact of currency, as well as gains on divestitures in 2019, coupled with higher input costs and increased investments in R&D. Currency net of pricing was a $10 million headwind, inclusive of $80 million in pricing actions. 4Q 4Q % % ($ in millions, except where noted) 2020 2019 Change Organic1 Change North America $845 $643 31% 31% EMEA $211 $226 (7)% (9)% Latin America $602 $615 (2)% 21% Asia Pacific $309 $256 21% 17% Total 4Q Crop Protection Net Sales $1,967 $1,740 13% 21% Crop Protection net sales were $6.5 billion in 2020, up 3% from $6.3 billion in 2019, with organic1 sales increases of 11%. Sales gains were driven by a 7% increase in volume and a 4% increase in local price, which was partially offset by a 7% impact from currency and a 1% impact from portfolio. The increase in volume was driven by continued penetration of new products globally, with combined sales of $1.0 billion in 2020 – up $265 million compared to the prior-year period – led by EnlistTM, ArylexTM and RinskorTM herbicides and IsoclastTM insecticide. Local price growth was driven by increases in Latin America to offset currency, coupled with favorable mix globally from new product launches. Unfavorable currency impacts were led by the Brazilian Real. The Company has recognized approximately $150 million in pricing to offset the weakening Brazilian Real for the full year. The portfolio impact was driven by divestitures in Asia Pacific and North America. Segment operating EBITDA was $1.0 billion in 2020, down from pro forma segment operating EBITDA of $1.1 billion in 2019. Favorable mix and ongoing cost and productivity actions, together with volume gains, were more than offset by the negative impact of currency, increased investment to fund growth and higher input costs. Currency net of pricing was a $70 million headwind, inclusive of $150 million in pricing actions. FY FY % % ($ in millions, except where noted) 2020 2019 Change Organic1 Change North America $2,373 $2,205 8% 8% EMEA $1,374 $1,362 1% 4% Latin America $1,688 $1,759 (4)% 17% Asia Pacific $1,026 $930 10% 14% Total FY Crop Protection Net Sales $6,461 $6,256 3% 11%


 
News Release 4Q/Full Year 5 Seed Summary Seed net sales were $1.2 billion in the fourth quarter of 2020, flat from the same period last year. Volume gains of 9% were offset by a 9% impact from currency. Volume growth was driven by strong Safrinha corn sales in Brazil, coupled with early season sales in North America and Europe. Unfavorable currency impacts were led by the Brazilian Real. Segment operating EBITDA was a seasonal loss of $(47) million in the fourth quarter of 2020, compared to a loss of $(26) million in the fourth quarter of 2019. Volume gains and ongoing cost and productivity actions were more than offset by the unfavorable impact of currency and higher input costs. 4Q 4Q % % ($ in millions, except where noted) 2020 2019 Change Organic1 Change North America $505 $486 4% 4% EMEA $206 $178 16% 21% Latin America $449 $494 (9)% 13% Asia Pacific $80 $85 (6)% (2)% Total 4Q Seed Net Sales $1,240 $1,243 --% 9% Seed net sales were approximately $7.8 billion in 2020, up 2% from approximately $7.6 billion in 2019. The increase was driven by a 5% increase in volume and a 1% increase in local price, partially offset by a 4% unfavorable impact from currency. Seed reported organic1 growth in all regions, led by strong sales in Latin America, market share gains in EMEA, and the recovery of soybean planted area in North America. Global corn price grew 2% year over year, primarily driven by continued penetration from products such as Qrome® and PowerCore ULTRA™. North America soybean price increased 2% versus the year-ago period due to superior product performance and strong execution. Unfavorable currency impacts were led by the Brazilian Real. Segment operating EBITDA was $1.2 billion in 2020, up 16% from pro forma segment operating EBITDA of $1.0 billion in 2019. Favorable mix, volume gains and ongoing cost and productivity actions more than offset the unfavorable impact of currency, higher input costs and higher royalties. FY FY % % ($ in millions, except where noted) 2020 2019 Change Organic1 Change North America $4,795 $4,724 2% 2% EMEA $1,468 $1,378 7% 12% Latin America $1,117 $1,130 (1)% 17% Asia Pacific $376 $358 5% 10% Total FY Seed Net Sales $7,756 $7,590 2% 6%


 
News Release 4Q/Full Year 6 Outlook The Company provided guidance8 for the full year 2021. Corteva expects net sales in the range of $14.4 billion to $14.6 billion, which at the mid-point represents expected net sales growth of 2% for the year and organic sales growth of 3% for the year. Operating EBITDA is expected to be in the range of $2.4 billion to $2.5 billion and operating EPS range is expected to be between $1.85 and $1.95 per share. In addition, the Company affirmed its mid-term targets as previously guided in 2019, including targeted compounded annual growth for Operating EBITDA of 12-16% from 2019 through 2022. Corteva is not able to reconcile its forward-looking non-GAAP financial measures to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of its control, such as significant items, without unreasonable effort. This outlook does not contemplate any extreme weather events, operational disruptions, significant changes in customers’ demand or ability to pay, or further acceleration of currency impacts resulting from the COVID-19 pandemic. Fourth Quarter Conference Call The Company will host a live webcast of its fourth quarter and full year 2020 earnings conference call with investors to discuss its results and outlook tomorrow, February 4, 2021, at 9:00 a.m. ET. The slide presentation that accompanies the conference call is posted on the Company’s Investor Events and Presentations page. A replay of the webcast will also be available on the Investor Events and Presentations page. About Corteva Corteva, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry – including a balanced and diverse mix of seed, crop protection and digital solutions focused on maximizing productivity to enhance yield and profitability. With some of the most recognized brands in agriculture and an industry-leading product and technology pipeline well positioned to drive growth, the Company is committed to working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva became an independent public company on June 1, 2019 and was previously the Agriculture Division of DowDuPont. More information can be found at www.corteva.com. Follow Corteva on Facebook, Instagram, LinkedIn, Twitter and YouTube. Cautionary Statement About Forward-Looking Statements This communication contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “guidance”, “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates,” “outlook,” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as expected benefits from, the separation of Corteva from DowDuPont, are forward looking statements. Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward- looking statements also involve risks and uncertainties, many of which are beyond Corteva’s control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva’s business, results of operations and financial condition. Some of the important factors that could cause Corteva’s actual results to differ materially from those projected in any such forward-looking statements include: i) failure to obtain or maintain the necessary regulatory approvals for some Corteva’s products; (ii) failure to successfully develop and commercialize Corteva’s pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) effect of competition and consolidation in Corteva’s industry; (vi) effect of competition from manufacturers of generic products; (vii) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (viii) effect of climate change and unpredictable seasonal and weather factors; (ix) risks related to oil and commodity markets; (x) competitor’s establishment of an intermediary platform for distribution of Corteva's products; (xi) impact of Corteva’s dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xii) effect of industrial espionage and other disruptions to Corteva’s supply chain, information technology or network systems; (xiii) effect of volatility in Corteva’s input costs; (xiv) failure to realize the anticipated benefits of the internal reorganizations taken by DowDuPont in connection with the spin-off of Corteva and other cost savings initiatives; (xv) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xvi) failure of Corteva’s customers to pay their debts to Corteva, including customer financing programs; (xvii) increases in pension and other post-employment benefit plan funding obligations; (xviii) risks related to the indemnification obligations of legacy EID liabilities in connection with the separation of Corteva; (xix) effect of compliance with laws and requirements and adverse judgments on litigation; (xx) risks related to Corteva’s global operations; (xxi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions; failure to enforce; (xxii) risks related to COVID-19; (xxiii) risks related to activist stockholders; (xxiv) Corteva’s intellectual property rights or defend against intellectual property claims asserted by others; (xxv) effect of counterfeit products; (xxvi) Corteva’s dependence on intellectual property cross-license agreements; and (xxvii) other risks related to the Separation from DowDuPont. Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the “Risk Factors” section of Corteva’s Annual Report on Form 10-K, as modified by subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K.


 
News Release 4Q/Full Year 7 Corteva Unaudited Pro Forma Financial Information In order to provide the most meaningful comparison of results of operations, supplemental unaudited pro forma financial information for the full year 2019 has been included in this presentation. This presentation presents the pro forma results of Corteva, after giving effect to events that are (1) directly attributable to the merger of DuPont and Dow, debt retirement transactions related to paying off or retiring portions of Historical DuPont’s existing debt liabilities, and the separation and distribution to DowDuPont stockholders of all the outstanding shares of Corteva common stock; (2) factually supportable and (3) with respect to the pro forma statements of income, expected to have a continuing impact on the consolidated results. Refer to Corteva’s Form 10 registration statement filed on May 6, 2019, which can be found on the investors section of the Corteva website, for further details on the above transactions. The pro forma financial statements were prepared in accordance with Article 11 of Regulation S-X, and are presented for informational purposes only, and do not purport to represent what the results of operations would have been had the above actually occurred on the dates indicated, nor do they purport to project the results of operations for any future period or as of any future date. Regulation G (Non-GAAP Financial Measures) This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures may include organic sales, organic growth (including by segment and region), operating EBITDA, pro forma operating EBITDA, operating EBITDA margin, pro forma operating EBITDA margin, operating earnings per share, pro forma operating earnings per share, base tax rate, and pro forma base tax rate. Management uses these measures internally for planning and forecasting, including allocating resources and evaluating incentive compensation. Management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide additional, useful information to investors as they provide insight with respect to ongoing operating results of the Company and a useful comparison of year over year results. These non-GAAP measures supplement the Company’s U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page A-6 of the Financial Statement Schedules. For the full year 2019, these non-GAAP measures are being reconciled to a pro forma GAAP financial measure prepared and presented in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. See Article 11 Pro Forma Combined Statements of Operations starting on page A-17 of the Financial Statement Schedules. Corteva is not able to reconcile its forward-looking non-GAAP financial measures to their most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of the Company’s control, such as Significant Items, without unreasonable effort. For Significant items reported in the periods presented, refer to page A-6 of the Financial Statement Schedules. Beginning January 1, 2020, the Company presents accelerated prepaid royalty amortization expense as a significant item. Accelerated prepaid royalty amortization represents the noncash charge associated with the recognition of upfront payments made to Monsanto in connection with the Company’s non-exclusive license in the United States and Canada for Monsanto’s Genuity® Roundup Ready 2 Yield® Roundup Ready 2 Xtend® herbicide tolerance traits. During the five-year ramp-up period of Enlist E3TM, Corteva is expected to significantly reduce the volume of products with the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform after the completion of the ramp-up. Additionally, on February 1, 2021, Corteva approved restructuring actions designed to right-size and optimize footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. Corteva expects to record total pre-tax restructuring and asset-related charges of approximately $130 million to $170 million. The restructuring actions associated with this charge are expected to be substantially complete in 2021. Organic sales is defined as price and volume and excludes currency and portfolio impacts. Operating EBITDA is defined as earnings (i.e., income from continuing operations before income taxes) before interest, depreciation, amortization, non-operating benefits, net and foreign exchange gains (losses) net, excluding the impact of significant items (including goodwill impairment charges). Non-operating benefits, net consists of non-operating pension and other post-employment benefit (OPEB) credits, tax indemnification adjustments, environmental remediation and legal costs associated with legacy businesses and sites of Historical DuPont. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the Company as pre-tax income or expense. Operating EBITDA margin is defined as Operating EBITDA as a percentage of net sales. Operating earnings per share are defined as “Earnings per common share from continuing operations - diluted” excluding the after-tax impact of significant items (including goodwill impairment charges), the after tax impact of non-operating benefits, net, and the after-tax impact of amortization expense associated with intangible assets existing as of the Separation from DowDuPont. Although amortization of the Company’s intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Base tax rate is defined as the effective tax rate excluding the impacts of foreign exchange gains (losses) net, non-operating benefits, net, amortization of intangibles as of the Separation from DowDuPont, and significant items (including goodwill impairment charges). The full year 2019 is on a pro forma basis as discussed above in the paragraph ‘Corteva Unaudited Pro Forma Financial Information’. ® TM Corteva Agriscience and its affiliated companies or their respective owned. 02/03/2021 Media Contact Gregg M. Schmidt +1 302-485-3260 gregg.m.schmidt@corteva.com Investor Contact Jeff Rudolph +1 302-485-3704 jeff.rudolph@corteva.com


 
Document
A-1
Corteva, Inc.
Consolidated Statements of Operations
(Dollars in millions, except per share amounts)
Three Months Ended December 31,Twelve Months Ended
December 31,
2020201920202019
Net sales$3,207 $2,983 $14,217 $13,846 
Cost of goods sold2,112 1,968 8,507 8,575 
Research and development expense305 290 1,142 1,147 
Selling, general and administrative expenses724 747 3,043 3,065 
Amortization of intangibles181 161 682 475 
Restructuring and asset related charges - net37 55 335 222 
Integration and separation costs— 50 — 744 
Other income - net92 125 212 215 
Loss on early extinguishment of debt— — — 13 
Interest expense10 24 45 136 
(Loss) income from continuing operations before income taxes(70)(187)675 (316)
Benefit from income taxes on continuing operations(169)(145)(81)(46)
Income (loss) from continuing operations after income taxes99 (42)756 (270)
(Loss) income from discontinued operations after income taxes(56)24 (55)(671)
Net income (loss)43 (18)701 (941)
Net income attributable to noncontrolling interests20 18 
Net income (loss) attributable to Corteva$41 $(21)$681 $(959)
Basic earnings (loss) per share of common stock:
Basic earnings (loss) per share of common stock from continuing operations$0.13 $(0.06)$0.98 $(0.38)
Basic (loss) earnings per share of common stock from discontinued operations(0.08)0.03 (0.07)(0.90)
Basic earnings (loss) per share of common stock$0.05 $(0.03)$0.91 $(1.28)
Diluted earnings (loss) per share of common stock:
Diluted earnings (loss) per share of common stock from continuing operations$0.13 $(0.06)$0.98 $(0.38)
Diluted (loss) earnings per share of common stock from discontinued operations(0.08)0.03 (0.07)(0.90)
Diluted earnings (loss) per share of common stock$0.05 $(0.03)$0.91 $(1.28)
Average number of shares outstanding used in earnings per share (EPS) calculation (in millions)
  Basic746.3749.6748.7749.5
  Diluted749.7749.6751.2749.5






A-2
Corteva, Inc.
Condensed Consolidated Balance Sheets
(Dollars in millions, except share amounts)
December 31,
2020
December 31,
2019
Assets
Current assets
Cash and cash equivalents$3,526 $1,764 
Marketable securities269 
Accounts and notes receivable, net4,926 5,528 
Inventories4,882 5,032 
Other current assets1,165 1,190 
Total current assets14,768 13,519 
Investment in nonconsolidated affiliates66 66 
Property, plant and equipment, net of accumulated depreciation
 December 31, 2020 - $3,857 and December 31, 2019 - $3,326
4,396 4,546 
Goodwill10,269 10,229 
Other intangible assets10,747 11,424 
Deferred income taxes464 287 
Other assets1,939 2,326 
Total Assets$42,649 $42,397 
Liabilities and Equity
Current liabilities
Short-term borrowings and finance lease obligations$$
Accounts payable3,615 3,702 
Income taxes payable123 95 
Accrued and other current liabilities4,807 4,434 
Total current liabilities8,548 8,238 
Long-Term Debt1,102 115 
Other Noncurrent Liabilities
Deferred income tax liabilities893 920 
Pension and other post employment benefits - noncurrent5,176 6,377 
Other noncurrent obligations1,867 2,192 
Total noncurrent liabilities9,038 9,604 
Commitments and contingent liabilities
Stockholders' equity
Common stock, $0.01 par value; 1,666,667,000 shares authorized;
issued at December 31, 2020 - 743,458,000 and December 31, 2019 - 748,577,000
Additional paid-in capital27,707 27,997 
Accumulated deficit— (425)
Accumulated other comprehensive loss(2,890)(3,270)
Total Corteva stockholders' equity24,824 24,309 
Noncontrolling interests239 246 
Total equity25,063 24,555 
Total Liabilities and Equity$42,649 $42,397 



A-3
Corteva, Inc.
Condensed Consolidated Statement of Cash Flows
(Dollars in millions, except per share amounts)

Twelve Months Ended
December 31,
2020
20191
Operating activities
Net income (loss)$701 $(941)
Adjustments to reconcile net income (loss) to cash provided by operating activities
Depreciation and amortization1,177 1,599 
Benefit from deferred income tax(330)(477)
Net periodic pension benefit(409)(264)
Pension contributions(62)(121)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments(142)
Goodwill impairment charge— 1,102 
Loss on early extinguishment of debt— 13 
Restructuring and asset related charges - net335 339 
Amortization of inventory step-up— 272 
Other net loss290 246 
Changes in operating assets and liabilities, net 359 (556)
Cash provided by operating activities2,064 1,070 
Investing activities
Capital expenditures(475)(1,163)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested83 249 
Acquisitions of businesses - net of cash acquired— (10)
Investments in and loans to nonconsolidated affiliates(1)(10)
Proceeds from sale of ownership interest in nonconsolidated affiliates— 21 
Purchases of investments(995)(138)
Proceeds from sales and maturities of investments721 160 
Other investing activities - net(7)(13)
Cash used for investing activities(674)(904)
Financing activities
Net change in borrowings (less than 90 days)— (1,868)
Proceeds from debt2,439 1,001 
Payments on debt(1,441)(6,804)
Repurchase of common stock(275)(25)
Proceeds from exercise of stock options56 47 
Dividends paid to stockholders(388)(194)
Payment for acquisition of subsidiary's interest from the non-controlling interest(60)— 
Distributions to DowDuPont— (317)
Contributions from Dow and DowDuPont— 7,396 
Cash transferred to DowDuPont at Internal Reorganizations— (2,053)
Debt extinguishment costs— (79)
Other financing activities, net(28)(33)
Cash provided by financing activities303 (2,929)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(88)
Increase (decrease) in cash, cash equivalents and restricted cash1,700 (2,851)
Cash, cash equivalents and restricted cash at beginning of period2,173 5,024 
Cash, cash equivalents and restricted cash at end of period$3,873 $2,173 
1.The cash flows for the twelve months ended December 31, 2019 includes cash flows of historical DuPont's ECP and Specialty Products Businesses.


A-4
Corteva, Inc.
Pro Forma Consolidated Statements of Operations1
(Dollars in millions, except per share amounts)
Three Months Ended December 31,Twelve Months Ended
December 31,
202020192020
20192
Net sales$3,207 $2,983 $14,217 $13,846 
Cost of goods sold2,112 1,968 8,507 8,386 
Research and development expense305 290 1,142 1,147 
Selling, general and administrative expenses724 747 3,043 3,068 
Amortization of intangibles181 161 682 475 
Restructuring and asset related charges - net37 55 335 222 
Integration and separation costs— 50 — 632 
Other income - net92 125 212 215 
Loss on early extinguishment of debt— — — 13 
Interest expense10 24 45 91 
(Loss) income from continuing operations before income taxes(70)(187)675 27 
(Benefit from) provision for income taxes on continuing operations(169)(145)(81)
Income (loss) from continuing operations after income taxes99 (42)756 26 
Net income from continuing operations attributable to noncontrolling interests20 13 
Net income (loss) from continuing operations attributable to Corteva$97 $(45)$736 $13 
Basic earnings (loss) per share of common stock from continuing operations$0.13 $(0.06)$0.98 $0.02 
Diluted earnings (loss) per share of common stock from continuing operations$0.13 $(0.06)$0.98 $0.02 
Average number of shares outstanding used in earnings per share (EPS) calculation (in millions)
  Basic746.3 749.6 748.7 749.5 
  Diluted749.7 749.6 751.2 749.5 

1.See Article 11 Pro Forma Combined Statements of Operations beginning on page A-18.
2.Period is presented on a Pro Forma Basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.






A-5
Corteva, Inc.
Consolidated Segment Information
(Dollars in millions, except per share amounts)

Three Months Ended
December 31,
Twelve Months Ended
December 31,
SEGMENT NET SALES - SEED2020
20191
2020
20191
    Corn$958 $962 $5,182 $5,126 
    Soybean63 74 1,445 1,387 
    Other oilseeds90 92 619 593 
    Other129 115 510 484 
Seed$1,240 $1,243 $7,756 $7,590 
Three Months Ended
December 31,
Twelve Months Ended
December 31,
SEGMENT NET SALES - CROP PROTECTION2020
20191
2020
20191
    Herbicides$965 $868 $3,280 $3,206 
    Insecticides546 494 1,764 1,652 
    Fungicides318 305 1,032 1,072 
    Other138 73 385 326 
Crop Protection$1,967 $1,740 $6,461 $6,256 
Three Months Ended
December 31,
Twelve Months Ended
December 31,
GEOGRAPHIC NET SALES - SEED2020201920202019
North America 2
$505 $486 $4,795 $4,724 
EMEA 3
206 178 1,468 1,378 
Latin America449 494 1,117 1,130 
Asia Pacific80 85 376 358 
Rest of World 4
735 757 2,961 2,866 
Net Sales$1,240 $1,243 $7,756 $7,590 
Three Months Ended
December 31,
Twelve Months Ended
December 31,
GEOGRAPHIC NET SALES - CROP PROTECTION2020201920202019
North America 2
$845 $643 $2,373 $2,205 
EMEA 3
211 226 1,374 1,362 
Latin America602 615 1,688 1,759 
Asia Pacific309 256 1,026 930 
Rest of World 4
1,122 1,097 4,088 4,051 
Net Sales$1,967 $1,740 $6,461 $6,256 
1. Prior periods have been reclassified to conform to current period presentation.
2. Reflects U.S. & Canada
3. Reflects Europe, Middle East, and Africa
4. Reflects EMEA, Latin America, and Asia Pacific




A-6
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
20202020
As ReportedAs Reported
Net Sales (GAAP)$3,207 $14,217 
    Less: Impacts from Currency and Portfolio(249)(758)
Organic Sales (Non-GAAP)$3,456 $14,975 
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2020201920202019
OPERATING EBITDAAs ReportedAs ReportedAs ReportedPro Forma
Seed$(47)$(26)$1,208 $1,040 
Crop Protection327 277 1,004 1,066 
Corporate Expenses(44)(27)(125)(119)
Operating EBITDA (Non-GAAP)$236 $224 $2,087 $1,987 
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2020201920202019
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS AFTER INCOME TAXES TO OPERATING EBITDAAs ReportedAs ReportedAs ReportedPro Forma
Income (loss) from continuing operations after income taxes (GAAP)$99 $(42)$756 $26 
(Benefit from) provision for income taxes on continuing operations(169)(145)(81)
(Loss) income from continuing operations before income taxes (GAAP)(70)(187)675 27 
Depreciation and amortization309 289 1,177 1,000 
Interest income(18)(13)(56)(59)
Interest expense10 24 45 91 
Exchange losses - net1
47 29 174 66 
Non-operating benefits - net2
(79)(23)(316)(129)
Significant items charge3
37 105 388 991 
Operating EBITDA (Non-GAAP)$236 $224 $2,087 $1,987 
1.Refer to page A-17 for pre-tax and after tax impacts of exchange losses (gains) - net. The twelve months ended December 31, 2019, on an operating basis (Non-GAAP), excludes a $(33) exchange loss associated with the devaluation of the Argentine peso, as it is included in significant items.
2.Non-operating benefits—net consists of non-operating pension and other post-employment benefit (OPEB) (benefits) costs, tax indemnification adjustments, environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.
3.Refer to page A-11 for pre-tax and after tax impacts of significant items.



A-7
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
PRICE - VOLUME - CURRENCY ANALYSIS
REGION
Q4 2020 vs. Q4 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$221 20 %$220 19 %%15 %%— %
EMEA
13 %17 %%%(1)%— %
Latin America(58)(5)%194 17 %%%(22)%— %
Asia Pacific48 14 %42 12 %%10 %%— %
Rest of World— %253 14 %%%(14)%— %
Total$224 %$473 16 %%10 %(8)%— %
SEED
Q4 2020 vs. Q4 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$19 %$18 %(5)%%— %— %
EMEA
28 16 %37 21 %%16 %(5)%— %
Latin America(45)(9)%63 13 %%%(22)%— %
Asia Pacific(5)(6)%(2)(2)%(1)%(1)%(4)%— %
Rest of World(22)(3)%98 13 %%10 %(16)%— %
Total$(3)— %$116 %— %%(9)%— %
CROP PROTECTION
Q4 2020 vs. Q4 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$202 31 %$202 31 %11 %20 %— %— %
EMEA
(15)(7)%(20)(9)%(1)%(8)%%— %
Latin America(13)(2)%131 21 %14 %%(23)%— %
Asia Pacific53 21 %44 17 %%15 %%%
Rest of World25 %155 14 %%%(12)%— %
Total$227 13 %$357 21 %10 %11 %(8)%— %

















A-8
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)

SEED PRODUCT LINE
Q4 2020 vs. Q4 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn2
$(4)— %$103 11 %%%(11)%— %
Soybeans2
(11)(15)%(7)(9)%%(10)%(6)%— %
Other oilseeds2
(2)(2)%— — %(16)%16 %(2)%— %
Other2
14 12 %20 17 %— %17 %(5)%— %
Total $(3)— %$116 %— %%(9)%— %
CROP PROTECTION PRODUCT LINE
Q4 2020 vs. Q4 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Herbicides2
$97 11 %$130 15 %%13 %(4)%— %
Insecticides2
52 11 %95 19 %%10 %(8)%— %
Fungicides2
13 %59 19 %12 %%(15)%— %
Other2
65 89 %73 100 %91 %%(10)%(1)%
Total$227 13 %$357 21 %10 %11 %(8)%— %



A-9
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
PRICE - VOLUME - CURRENCY ANALYSIS
REGION
Twelve Months 2020 vs. Twelve Months 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$239 %$266 %%%(1)%— %
EMEA
102 %$212 %%%(4)%— %
Latin America(84)(3)%$490 17 %%10 %(20)%— %
Asia Pacific114 %$161 13 %%11 %(3)%(1)%
Rest of World132 %863 12 %%%(10)%— %
Total$371 %$1,129 %%%(5)%— %
SEED
Twelve Months 2020 vs. Twelve Months 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$71 %$84 %— %%— %— %
EMEA
90 %163 12 %%%(5)%— %
Latin America(13)(1)%187 17 %%13 %(18)%— %
Asia Pacific18 %35 10 %%%(5)%— %
Rest of World95 %385 13 %%%(10)%— %
Total$166 %$469 %%%(4)%— %
CROP PROTECTION
Twelve Months 2020 vs. Twelve Months 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$168 %$182 %%%— %— %
EMEA
12 %49 %%%(2)%(1)%
Latin America(71)(4)%303 17 %%%(21)%— %
Asia Pacific96 10 %126 14 %%13 %(2)%(2)%
Rest of World37 %478 12 %%%(10)%(1)%
Total$205 %$660 11 %%%(7)%(1)%



A-10
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SEED PRODUCT LINE
Twelve Months 2020 vs. Twelve Months 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn2
$56 %$300 %%%(5)%— %
Soybeans2
58 %83 %%%(2)%— %
Other oilseeds2
26 %46 %— %%(4)%— %
Other2
26 %40 %%%(3)%— %
Total $166 %$469 %%%(4)%— %
CROP PROTECTION PRODUCT LINE
Twelve Months 2020 vs. Twelve Months 2019Percent Change Due To:
Net Sales Change (GAAP)
Organic Change 1 (Non-GAAP)
Local Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Herbicides2
$74 %$241 %%%(5)%(1)%
Insecticides2
112 %232 14 %%%(7)%— %
Fungicides2
(40)(4)%105 10 %%%(12)%(2)%
Other2
59 18 %82 25 %24 %%(7)%— %
Total$205 %$660 11 %%%(7)%(1)%

1.Organic sales is defined as price and volume and excludes currency and portfolio impacts.
2.Prior periods have been reclassified to conform to current period presentation.




A-11
Corteva, Inc.
Significant Items
(Dollars in millions, except per share amounts)
SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2020201920202019
As ReportedAs ReportedAs ReportedPro Forma
Seed$(11)$(90)$(165)$(304)
Crop Protection(11)(162)(23)
Corporate(15)(16)(61)(664)
Total significant items before income taxes$(37)$(105)$(388)$(991)
SIGNIFICANT ITEMS - PRE-TAX, AFTER TAX, AND EPS IMPACTS
Pre-tax
After tax9
($ Per Share)
202020192020201920202019
1st QuarterAs ReportedPro FormaAs ReportedPro FormaAs ReportedPro Forma
Integration costs 1
$— $(100)$— $(16)$— $(0.02)
Restructuring and asset related charges, net 2
(70)(61)(57)(53)(0.08)(0.07)
Loss on divestiture 3
(53)(24)(43)(24)(0.06)(0.03)
Income tax items 4
— — (19)— (0.02)— 
1st Quarter - Total$(123)$(185)$(119)$(93)$(0.16)$(0.12)
2nd QuarterAs ReportedAs ReportedAs ReportedAs ReportedAs ReportedAs Reported
Integration and separation costs 1
$— $(330)$— $(436)$— $(0.58)
Restructuring and asset related charges, net 2
(179)(60)(143)(48)(0.19)(0.06)
Amortization of inventory step up 5
— (52)— (41)— (0.06)
Loss on early extinguishment of debt 6
— (13)— (10)— (0.01)
Income tax items 4
— — 29 — 0.04 — 
2nd Quarter - Total$(179)$(455)$(114)$(535)$(0.15)$(0.71)
3rd QuarterAs ReportedAs ReportedAs ReportedAs ReportedAs ReportedAs Reported
Integration and separation costs 1
$— $(152)$— $(119)$— $(0.16)
Restructuring and asset related charges, net 2
(49)(46)(27)(34)(0.04)(0.04)
Amortization of inventory step up 5
— (15)— (15)— (0.02)
Argentina currency devaluation 7
— (33)— (38)— (0.05)
Income tax items4
— — — 38 — 0.05 
3rd Quarter - Total$(49)$(246)$(27)$(168)$(0.04)$(0.22)
4th QuarterAs ReportedAs ReportedAs ReportedAs ReportedAs ReportedAs Reported
Integration and separation costs 1
$— $(50)$— $20 $— $0.03 
Restructuring and asset related charges, net 2
(37)(55)(32)(42)(0.04)(0.06)
Income tax items4
— — 182 34 0.24 0.05 
4th Quarter - Total$(37)$(105)$150 $12 $0.20 $0.02 
Year-to-date Total 8
$(388)$(991)$(110)$(784)$(0.15)$(1.04)

1.Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with the preparation and execution of these activities. For periods prior to Q2 2019, this includes only integration costs.


A-12
Corteva, Inc.
Significant Items
(Dollars in millions, except per share amounts)

The after-tax benefit for the fourth quarter of 2019 includes a net tax benefit of $48 related to application of the U.S. Tax Reform’s foreign tax provisions.

The after-tax charge for the third quarter of 2019 includes a net tax benefit of $13 related to application of the U.S. Tax Reform’s foreign tax provisions.

The after-tax charge for the second quarter of 2019 includes a net tax charge of $(114) related to U.S. state blended tax rate changes associated with the Internal Reorganizations and a net tax charge of $(96) related to application of the U.S. Tax Reform’s foreign tax provisions.

The after-tax charge for the first quarter of 2019 includes a net tax charge of $(32) related to U.S. state blended tax rate changes associated with the Internal Reorganizations and a tax benefit of $102 related to an internal legal entity restructuring associated with the Internal Reorganizations.

2.Fourth quarter, third quarter, second quarter, and first quarter 2020 included restructuring and asset related charges of $(37), $(49), $(179) and $(70), respectively. The charge for the fourth quarter included a $(42) charge related to the Execute to Win Productivity Program, a $(1) charge related to non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits, and a $6 benefit associated with the DowDuPont Synergy Program. The charge for the third quarter included a $(30) charge related to the Execute to Win Productivity Program, a $(10) charge related to non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits, and a $(9) charge associated with the DowDuPont Synergy Program. The charge for the second quarter included a $(41) charge related to the Execute to Win Productivity Program and a $(138) charge related to non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits. The charge for the first quarter included a $(63) charge related to the Execute to Win Productivity Program, a $(10) charge related to non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits, and a $3 asset related benefit associated with the DowDuPont Synergy Program.

The after-tax charge for the third quarter of 2020 includes a net tax benefit of $11 related to a change in estimate on the full year impact of The Act's foreign provisions.

Fourth quarter, third quarter, second quarter, and first quarter 2019 included restructuring and asset related charges of $(55), $(46), $(60) and $(61), respectively. The charge for the fourth quarter included a $(90) non-cash intangible asset impairment charge as a result of the company’s decision to accelerate the ramp up of the Enlist E3TM trait platform in the company’s soybean portfolio mix across all brands, including Pioneer brands, over the next five years with minimal use of the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® traits thereafter for the remainder of the Roundup Ready 2 License Agreement. This charge was partially offset by a benefit of $22 associated with the DowDuPont Cost Synergy Program and a benefit of $13 associated with the DowDuPont Agriculture Division Restructuring Program. The charge for the third quarter included a $(54) non-cash asset impairment related to certain intangible assets that primarily relate to heritage Dow AgroSciences intangibles previously acquired from Cooperativa Central de Pesquisa Agrícola's ("Coodetec"), classified as developed technology, other intangible assets and in-process research and development ("IPR&D"), partially offset by a benefit of $8 associated with the DowDuPont Cost Synergy Program. The charge for the first and second quarter is primarily related to the DowDuPont Cost Synergy Program.

3.First quarter 2020 includes a loss of $(53) included in other income - net related to the expected sale of the La Porte site, for which the company signed an agreement during the first quarter 2020.

First quarter 2019 includes a loss of $(24) included in other income - net related to DAS's sale of a joint venture related to synergy actions.

4.Fourth quarter 2020 reflects an after-tax benefit related to Swiss Tax Reform. Second quarter 2020 reflects a benefit of $29 due to an elective change in accounting method that alters the 2019 impact of the business separation on the 2017 Tax Cuts and Jobs Act's foreign tax provisions. First quarter 2020 includes an after tax charge related to the impact of a state tax valuation allowance in the U.S. based on a change in judgment about the realizability of a deferred tax asset.

Fourth quarter 2019 reflects an after-tax benefit related to the impact of the release of a tax valuation allowance recorded against the net deferred tax asset position of a Swiss legal entity.

Third quarter 2019 reflects an after-tax benefit related to Swiss Tax Reform.

5.Third quarter and second quarter 2019 includes amortization of inventory step up reflected in cost of goods sold related to the amortization of the inventory step-up in connection with the Merger.



A-13
Corteva, Inc.
Significant Items
(Dollars in millions, except per share amounts)
6.Second quarter 2019 includes a loss on the early extinguishment of debt related to the difference between the redemption price and the par value of the Make Whole Notes and Term Loan Facility, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID's debt.

7.Third quarter 2019 includes a $(33) loss included in other income - net associated with remeasuring the company’s Argentine Peso net monetary assets, resulting from an unexpected August primary election result in Argentina.  Throughout the three months ended September 30, 2019, the Argentine Peso dropped approximately a third of its value against the U.S. dollar and in September of 2019, the country’s central bank announced new restrictions on foreign currency transactions. The after tax charge of $(38) includes a tax valuation allowance recorded against the net deferred tax asset position of an Argentine legal entity.

8.Earnings per share for the year may not equal the sum of quarterly earnings per share due to the changes in average share calculations.

9.Unless specifically addressed in notes above, the income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.




A-14
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
Operating Earnings Per Share (Non-GAAP)
Operating earnings per share is defined as earnings per share from continuing operations – diluted, excluding non-operating benefits - net, amortization of intangibles (existing as of Separation) and significant items.
Three Months Ended
December 31,
2020201920202019
$$EPS (diluted)EPS (diluted)
Net income (loss) from continuing operations attributable to Corteva (GAAP)$97 $(45)$0.13 $(0.06)
Less: Non-operating benefits - net, after tax 1
57 16 0.08 0.02 
Less: Amortization of intangibles (existing as of Separation), after tax(141)(126)(0.19)(0.17)
Less: Significant items benefit, after tax150 12 0.20 0.02 
Operating Earnings (Non-GAAP)$31 $53 $0.04 $0.07 
Twelve Months Ended
December 31,
2020
20192
2020
20192
$$EPS (diluted)EPS (diluted)
Net income from continuing operations attributable to Corteva (GAAP)$736 $13 $0.98 $0.02 
Less: Non-operating benefits - net, after tax 1
237 100 0.32 0.13 
Less: Amortization of intangibles (existing as of Separation), after tax(518)(376)(0.69)(0.50)
Less: Significant items charge, after tax(110)(784)(0.15)(1.04)
Operating Earnings (Non-GAAP)$1,127 $1,073 $1.50 $1.43 
1.Non-operating benefits—net consists of non-operating pension and other post-employment benefit (OPEB) benefits (costs), tax indemnification adjustments, and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.
2.Periods are presented on a Pro Forma Basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.


A-15
Corteva, Inc.
Operating EBITDA to Operating Earnings Per Share
(Dollars in millions, except per share amounts)

Operating EBITDA to Operating Earnings Per Share
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2020201920202019
As ReportedAs ReportedAs ReportedPro Forma
Operating EBITDA (Non-GAAP)1
$236 $224 2,087 1,987 
Depreciation(128)(128)(495)(525)
Interest Income18 13 56 59 
Interest Expense(10)(24)(45)(91)
Provision for income taxes on continuing operations before significant items, non-operating benefits - net, amortization of intangibles (existing as of Separation), and exchange gains/(losses), net (Non-GAAP)1
(46)(15)(295)(280)
Base income tax rate from continuing operations (Non-GAAP)1
39.7 %17.6 %18.4 %19.6 %
Exchange losses - net, after tax2
(37)(14)(161)(64)
Net income attributable to non-controlling interests(2)(3)(20)(13)
Operating Earnings (Non-GAAP)1
$31 $53 $1,127 $1,073 
Diluted Shares (in millions)749.7 749.6 751.2 749.5 
Operating Earnings Per Share (Non-GAAP)1
$0.04 $0.07 $1.50 $1.43 
1.     Refer to pages A-6 through A-10 for Non-GAAP reconciliations.
2.     Refer to page A-17 for pre-tax and after tax impacts of exchange gains (losses) - net.





A-16
Corteva, Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions)

Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, amortization of intangibles (existing as of Separation), and non-operating benefits - net.
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2020201920202019
As ReportedAs ReportedAs ReportedPro Forma
(Loss) income from continuing operations before income taxes (GAAP)
$(70)$(187)$675 $27 
Add: Significant items - charge 1
37 105 388 991 
           Non-operating benefits - net(79)(23)(316)(129)
           Amortization of intangibles (existing as of Separation)181 161 682 475 
Less: Exchange losses, net 2,3
(47)(29)(174)(66)
Income from continuing operations before income taxes, significant items, non-operating benefits - net, amortization of intangibles (existing as of Separation), and exchange losses, net (Non-GAAP)
$116 $85 $1,603 $1,430 
(Benefit from) provision for income taxes on continuing operations (GAAP)
$(169)$(145)$(81)$
Add: Tax benefits on significant items charge1
187 117 278 207 
          Tax expenses on non-operating benefits - net(22)(7)(79)(29)
          Tax benefits on amortization of intangibles (existing as of Separation)40 35 164 99 
          Tax benefits on exchange losses, net2
10 15 13 
Provision for income taxes on continuing operations before significant items, non-operating benefits - net, amortization of intangibles (existing as of Separation), and exchange losses, net (Non-GAAP)
$46 $15 $295 $280 
Effective income tax rate (GAAP)
241.4 %77.5 %(12.0)%3.7 %
Significant items, non-operating benefits, and amortization of intangibles (existing as of Separation) effect(189.2)%(77.5)%31.7 %16.7 %
Tax rate from continuing operations before significant items, non-operating benefits - net, and amortization of intangibles (existing as of Separation) (Non-GAAP)
52.2 %— %19.7 %20.4 %
Exchange losses, net effect2
(12.5)%17.6 %(1.3)%(0.8)%
Base income tax rate from continuing operations (Non-GAAP)
39.7 %17.6 %18.4 %19.6 %
1. See Significant Items table for further detail.
2. See page A-17 for further details of exchange gains (losses).
3. Pre-tax exchange gains (losses), net for the twelve months ended December 31, 2019, on an operating earnings basis (Non-GAAP), excludes a $(33) exchange loss associated with the devaluation of the Argentine peso as it is included within significant items.




A-17
Corteva, Inc.
(Dollars in millions, except per share amounts)

Exchange Gains/Losses
The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2020201920202019
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gains (losses)$37 $18 $(263)$(8)
Local tax (expenses) benefits(10)34 (11)
Net after tax impact from subsidiary exchange gains (losses)$27 $22 $(229)$(19)
Hedging Program (Loss) Gain
Pre-tax exchange (losses) gains$(84)$(47)$89 $(58)
Tax benefits (expenses) 20 11 (21)13 
Net after tax impact from hedging program exchange (losses) gains$(64)$(36)$68 $(45)
Total Exchange Loss
Pre-tax exchange losses1
$(47)$(29)$(174)$(66)
Tax benefits 10 15 13 
Net after tax exchange losses$(37)$(14)$(161)$(64)
As shown above, the "Total Exchange Loss" is the sum of the "Subsidiary Monetary Position Loss" and the "Hedging Program (Loss) Gain."
1.Pre-tax exchange (losses) gains, net for the twelve months ended December 31, 2019, on an operating earnings basis (Non-GAAP), excludes a $(33) exchange loss associated with the devaluation of the Argentine peso as it is included within significant items.




A-18
Corteva, Inc.
Article 11 Pro Forma Combined Statement of Operations
(Dollars in millions, except per share amounts)


Twelve Months Ended
December 31, 2019
As Reported CortevaAdjustmentsPro Forma Corteva
Merger1
Debt Retirement2
Separations Related3
Net sales$13,846 $ $ $ $13,846 
Cost of goods sold8,575 (205)— 16 8,386 
Research and development expense1,147 — — — 1,147 
Selling, general and administrative expenses3,065 — — 3,068 
Amortization of intangibles475 — — — 475 
Restructuring and asset related charges - net222 — — — 222 
Integration and separation costs744 — — (112)632 
Other income - net215 — — — 215 
Loss on early extinguishment of debt13 — — — 13 
Interest expense136 — (45)